#AGMB
LightNews LightNews
liquiditynews.bsky.social
Trading Resumed for $AGMB AgomAb Therapeutics NV ADS | at 09:48:58 ET on NASDAQ | 2026-10-30
October 30, 2026 at 1:52 PM
liquiditynews.bsky.social
Trading Halted for $AGMB AgomAb Therapeutics NV ADS | at 09:38:58.663 ET on NASDAQ | Volatility Trading Pause | 2026-10-30
October 30, 2026 at 1:43 PM
capitalsnitch.bsky.social
AgomAb Therapeutics NV insider buying: director Epstein David R bought $44K of $AGMB stock in open-market trades.

Filing details: https://capitalsnitch.com/stock/AGMB
Not financial advice.
The C-suite left a paper trail. We read it for you. CapitalSnitch.
#InsiderBuying #stocks #investing
AGMB insider trading, Congress trades & who owns it · CapitalSnitch
Every SEC insider buy and sale in AGMB, fund ownership and Congress trades, updated daily.
capitalsnitch.com
October 22, 2026 at 1:50 PM
quant-hub.bsky.social
🚨 $AGMB
Epstein David R (Insider) bought 10,000 shares at an average price of $8.8800 per common share. (Date: 2026-10-21)
SEC Filing: AGMB
Click to view the official SEC document.
www.sec.gov
October 22, 2026 at 12:15 PM
chalni.com
#$AGMB AgomAb Therapeutics
Director David R Epstein bought $88,800 of shares on 21 Oct (SEC filing, 22 Oct).
Holding +67%

Every real insider buy, noise removed: chalni.com
#insiderbuying #stocks
Real insider buys, last 5 trading days · Chalni
Top managers and directors buying their own company's shares, from SEC Form 4 filings. Pay plans, funds, pre-planned trades and private deals removed.
chalni.com
October 23, 2026 at 11:53 AM
elixstocksdata.bsky.social
AgomAb Therapeutics ($AGMB) – Insider Purchase

• Insider: David R Epstein, Director
• Bought: 10,000 shares (about $89K)
• Price: about $8.88 a share · Oct 21
• Filed: Oct 22 · Form 4

📊 More at www.elixstocks.com

Educational only. Not investment advice.

#InsiderBuying #Stocks
David R Epstein (Director) bought $89K of AgomAb Therapeutics ($AGMB)
Form 4 filed Oct 22. Every line of the filing.
elixstocks.com
October 22, 2026 at 12:15 PM
yarako.com
$AGMB: CEO Tim Jasper Knotnerus of AgomAb Therapeutics NV reported purchasing $94k of shares on Oct 6. Activity Score 42/100.
https://yarako.com/insider-buying/AGMB

Data from SEC Form 4 filings. For information only. Not investment advice. Past insider purchases do not predict future returns.
$AGMB insider purchases on Yarako
Open-market insider purchases reported on SEC Form 4. Information only, not advice.
yarako.com
October 20, 2026 at 2:07 PM
stocktitan.net
#AGMB Agomab Announces First Patient Dosed in Global NOV-ERA Phase 2b Study of Ontunisertib in Fibrostenosing Crohn's Disease

https://www.stocktitan.net/news/AGMB/agomab-announces-first-patient-dosed-in-global-nov-era-phase-2b-ay0gg07817ba.html?utm_source=stocktitan-bluesky&utm_medium=social
Agomab Announces First Patient Dosed in Global NOV-ERA Phase 2b Study of Ontunisertib in Fibrostenosing Crohn's Disease
Stock Titan provides an ultra-fast stock market news feed and multiple tools for traders and investors.
www.stocktitan.net
October 13, 2026 at 8:05 PM
insiderprint.bsky.social
Cluster buy: 3 insiders at AgomAb Therapeutics NV ($AGMB) bought $311K of stock, including the CEO.

Their avg. price $8.64. Stock now $9.08 (+5.0%).

https://www.insiderprint.com/ticker/AGMB?utm_source=bluesky&utm_medium=social&utm_campaign=cluster

#InsiderBuying #Healthcare
AgomAb Therapeutics NV (AGMB) insider buying
3 insiders bought $311K.
www.insiderprint.com
October 11, 2026 at 4:01 AM
quant-hub.bsky.social
🚨 $AGMB
Epstein David R (Insider) bought 5,000 shares at an average price of $8.9000 per common share. (Date: 2026-10-08)
SEC Filing: AGMB
Click to view the official SEC document.
www.sec.gov
October 9, 2026 at 12:02 PM
insiderbid.bsky.social
Epstein David R, Director at $AGMB, raised their own stake by 50% — bought 5,000 shares (~$45K) on the open market.
https://insiderbid.com/insider/0001445826
October 9, 2026 at 12:04 PM
elixstocksdata.bsky.social
AgomAb Therapeutics ($AGMB): Director buys shares
David R Epstein: +5,000 shares (about $44K)
About $8.90 a share · Oct 8
3 insiders bought in the last 30 days
SEC Form 4 · filed Oct 9
#InsiderBuying #Stocks

Visit for more info: www.elixstocks.com
Educational only. Not investment advice.
David R Epstein (Director) bought $44K of AgomAb Therapeutics ($AGMB)
Form 4 filed Oct 9. Every line of the filing.
elixstocks.com
October 9, 2026 at 12:43 PM
quant-hub.bsky.social
🚨 $AGMB
Epstein David R (Insider) bought 10,000 shares at an average price of $8.6350 per common share. (Date: 2026-10-06)
SEC Filing: AGMB
Click to view the official SEC document.
www.sec.gov
October 7, 2026 at 12:58 PM
amberallocates.substack.com
CFO of $AGMB just bought $26K CFO insider buys average +2.75% excess returns at 7 days (n=1,528, t=8.41).
October 7, 2026 at 6:00 PM
quant-hub.bsky.social
🚨 $AGMB
Epstein David R (Insider) bought 10,000 shares at an average price of $8.6350 per common share. (Date: 2026-10-06)
SEC Filing: AGMB
Click to view the official SEC document.
www.sec.gov
October 7, 2026 at 12:58 PM
quant-hub.bsky.social
🚨 $AGMB
Kemula Pierre Thadee Victor (Chief Financial Officer) bought 10,000 shares at an average price of $8.5940 per common share. (Date: 2026-10-06)
SEC Filing: AGMB
Click to view the official SEC document.
www.sec.gov
October 7, 2026 at 12:47 PM
quant-hub.bsky.social
🚨 $AGMB
Kemula Pierre Thadee Victor (Chief Financial Officer) bought 10,000 shares at an average price of $8.5940 per common share. (Date: 2026-10-06)
SEC Filing: AGMB
Click to view the official SEC document.
www.sec.gov
October 7, 2026 at 12:48 PM
quant-hub.bsky.social
🚨 $AGMB
Knotnerus Tim Jasper (Chief Executive Officer) bought 11,000 shares at an average price of $8.5800 per common share. (Date: 2026-10-06)
SEC Filing: AGMB
Click to view the official SEC document.
www.sec.gov
October 7, 2026 at 12:07 PM
quant-hub.bsky.social
🚨 $AGMB
Knotnerus Tim Jasper (Chief Executive Officer) bought 11,000 shares at an average price of $8.5800 per common share. (Date: 2026-10-06)
SEC Filing: AGMB
Click to view the official SEC document.
www.sec.gov
October 7, 2026 at 12:07 PM
amberallocates.substack.com
CFO of $AGMB just bought $43K CFO insider buys average +2.75% excess returns at 7 days (n=1,528, t=8.41).
October 7, 2026 at 2:00 PM
insiderbid.bsky.social
Epstein David R, Director at $AGMB, raised their own stake by 100% — bought 5,000 shares (~$44K) on the open market.
https://insiderbid.com/insider/0001445826
October 7, 2026 at 12:58 PM
elixstocksdata.bsky.social
AgomAb Therapeutics ($AGMB): Director buys shares
David R Epstein: +10,000 shares (about $86K)
About $8.63 a share · Oct 5-6
3 insiders bought in the last 30 days
SEC Form 4 · filed Oct 7
#InsiderBuying #Stocks

Follow @elixstocksdata for daily institutional & insider activity.
David R Epstein (Director) bought $86K of AgomAb Therapeutics ($AGMB)
Form 4 filed Oct 7. Every line of the filing.
elixstocks.com
October 7, 2026 at 12:58 PM
tradeinsight.info
CEO, CFO, and a Director at #AGMB all bought in early October, dropping a combined $266K to boost their holdings by 16% to 50% each. Coordinated buying is rarely accidental.
October 7, 2026 at 2:38 PM
insiderbid.bsky.social
Kemula Pierre Thadee Victor, Chief Financial Officer at $AGMB, raised their own stake by 167% — bought 5,000 shares (~$43K) on the open market.
https://insiderbid.com/insider/0002119332
October 7, 2026 at 12:48 PM
elixstocksdata.bsky.social
AgomAb Therapeutics ($AGMB): CEO buys shares
Tim Jasper Knotnerus: +11,000 shares (about $94K)
About $8.58 a share · Oct 5-6
Now holds 21,823 shares directly
SEC Form 4 · filed Oct 7
#InsiderBuying #Stocks

Follow @elixstocksdata for daily institutional & insider activity.
Tim Jasper Knotnerus (CEO) bought $94K of AgomAb Therapeutics ($AGMB)
Form 4 filed Oct 7. Every line of the filing.
elixstocks.com
October 7, 2026 at 12:30 PM